HAYWARD, Calif., May 28, 2014 /PRNewswire/ -- Questcor
Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it has
been honored with a "Recognition of Appreciation" Award from MS
Views & News, Inc., a leading multiple sclerosis (MS)
education, information and advocacy organization.
"We are very proud to recognize Questcor for its exemplary
support in helping to provide services to the multiple sclerosis
community," said Stuart Schlossman,
President and founder of MS Views & News. "Because of
Questcor's steadfast dedication to the not-for-profit community, MS
Views and News is readily able to reach out to tens of thousands of
people affected by multiple sclerosis, including their caregivers
and healthcare providers."
Mr. Schlossman presented the award today to Questcor at a
special reception held in conjunction with the Consortium of
Multiple Sclerosis Centers Meeting & Exhibition being held at
the Hilton Anatole in Dallas. Questcor vice presidents
Fran Olson and Darlene Romine together accepted the award on
behalf of the company.
"Questcor is honored to receive this recognition from MS Views
& News," said Steve Cartt,
Questcor's Chief Operating Officer. "We are committed to
serving the needs of MS patients, their families and the healthcare
providers who care for them. Our work together has helped
bridge an information and awareness gap related to the care of
patients suffering from MS relapses, an area of medicine that
historically has received little attention. We look forward
to continuing this important partnership in the future and
furthering these important educational efforts for MS
patients."
About Multiple Sclerosis:
Multiple sclerosis (MS)
involves an immune-mediated process in which an abnormal
response of the body's immune system is directed against the
central nervous system (CNS), which is made up of the brain, spinal
cord and optic nerves. The exact antigen — or target that the
immune cells are sensitized to attack — remains unknown, which is
why MS is considered by many experts to be "immune-mediated" rather
than "autoimmune." Within the CNS, the immune system attacks
myelin — the fatty substance that surrounds and insulates the nerve
fibers — as well as the nerve fibers themselves. The damaged
myelin forms scar tissue (sclerosis), which gives the disease its
name. When any part of the myelin sheath or nerve fiber is
damaged or destroyed, nerve impulses traveling to and from the
brain and spinal cord are distorted or interrupted, producing a
wide variety of symptoms.
About MS Views & News:
MS Views and News is
dedicated to the global collection and distribution of information
concerning multiple sclerosis. The organization provides
educational MS information via the Internet using its website,
blog, e-Newsletter, YouTube Channel and social media. For
more information, please visit www.msviews.org
About Questcor Pharmaceuticals
Questcor
Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune
and inflammatory disorders. Questcor's specific areas of focus are
in the fields of neurology, nephrology, pulmonology and
rheumatology, and the company is currently supporting research
efforts in a variety of conditions having significant unmet medical
need. For more information about Questcor, please visit
www.Questcor.com.
SOURCE Questcor Pharmaceuticals, Inc.